News

The Allergenic Products Advisory Committee voted in favor Friday to support the BLA data for what could become the first drug indicated for food allergy desensitization.

Lab tests confirm low levels of NDMA in the popular heart burn medication, sparking a probe in the US and Europe.

A pair of new mesh products will optimize hernia surgery, while reinforcing soft tissue with twice the strength.

A study from Brigham and Women's Hospital found asking clinicians if they would be surprised if older patients would die in the next month could save patients money on healthcare and improve quality of end-of-life care.

The aim of the “Alzheimer’s Disease Exposome” will be to identify new interactions of risk genes for future studies.

A recent analysis that included data on 284 patients found that more than 80% of patients with resistant hypertension also had obstructive sleep apnea.

The biologic becomes the first in its drug class to be indicated for patients aged 6-11 years old with the difficult-to-treat condition.

The FDA-approved drug targets IBS-C patients by increasing bowel movements, while lowering abdominal pain.

Through clinical trials, investigators find that SGLT2 inhibitors are not only safe, but have several cardiovascular benefits.

How patterns and trends in diet and lifestyle have influenced gastroenterology health.

A group of 370 leading healthcare organizations have sent a letter to congress in support of a bipartisan bill that would protect Medicare Advantage Beneficiaries from delays caused by prior authorizations.

Obstructive sleep apnea has been consistently underdiagnosed in US populations. Are screening methods enough?

The scope and scale of kidney disease is on the rise—much like its most commonly associated conditions.

A recent study found the lifetime risk of peripheral artery disease in black patients was around 30% while Hispanic and white patients had prevalence rates around 20%.

FDA announced the approval of the glucagon (Gvoke) injection for the treatment of severe hypoglycemic events in diabetic patients ages 2 and up on September 10.

A recent study found that 10% of the drugs and devices approved by the FDA during the study period were based on non-randomized clinical trials.

A recent study from investigators at the Rutgers Robert Wood Medical School found that rates of hypertension among pregnant women have spiked between 1970 and 2010.

Addressing the drivers of poor sleep conditions is among the many ways a physician can treat patients without prescription.

Acadia Pharmaceuticals has announced positive findings for time to psychosis relapse in dementia patients, which resulted in the trial's early end.

By allocating 1% of their day to exercise, patients can turn an unhealthy lifestyle into a healthy lifestyle.

Analysis of the FAST trial found that methotrexate performed better head-to-head than mycophenolate mofetil as a corticosteroid-sparing therapy.

Approximately 700,000 adults in the US as of 2016 are suffering from end-stage kidney disease, with transplantation viewed as the preferred treatment.

Recent research advances have associated the gut's health to overall patient health. What do we know now?

After success in multiple clinical trials, officials tout esketamine as a treatment for both major depressive disorder with active suicidal ideation and treatment resistant depression.

Deepak Bhatt, MD, executive director of Interventional Cardiovascular Programs at Brigham and Women's Hospital, offers perspective on the THEMIS and THEMIS-PCI trials.

A study from the University of California San Francisco found that patients with HIV were at an 80% increased risk of suffering from atrial fibrillation.

Dhruv Kazi, MD, of Beth Israel Deaconess Medical Center, discusses a recent study he led into the cost-effectiveness of polypill and why we do not see the approach applied to cardiovascular disease in the US.

Suraj Kapa, MD, takes part in an episode of DocTalk where he discusses the results of a recent study he led and how to implement technology into cardiology in a way that benefits patients and physicians.

Investigators report positive results using esketamine spray to treat patients with major depressive disorder.

In a retrospective study using the data of 20,741 patients, investigators discover the primary cause of emergency department visits for geriatric patients is head trauma.